Latest Pharmaceuticals policy Stories

RetireSafe Joins with More than 330 Organizations in Calling On Congress to Preserve Medicare Part D for America's Seniors

2013-03-19 16:29:32

WASHINGTON, March 19, 2013 /PRNewswire-USNewswire/ -- RetireSafe, representing 400,000 senior supporters across America, today joined more than 330 organizations in a letter urging Washington to reject changes to the popular Medicare prescription drug plan. In the common sense language of RetireSafe's supporters, "if it ain't broke, don't fix it." "Nearly 40 million seniors rely on Part D for access to prescription drugs. Ninety percent of beneficiaries are pleased with the way the...

ER Patients Say They Fill More Prescriptions Than They Do

2013-03-19 12:27:54

WASHINGTON, March 19, 2013 /PRNewswire-USNewswire/ -- Even when supported by patient-centered prescription information and services, a substantial proportion of patients who say that they fill their prescription medicines do not, according to a study published online last Friday in Annals of Emergency Medicine ("The Validity of Self-Reported Primary Adherence Among Medicaid Patients Discharged from the Emergency Department with a Prescription Medication"). (Logo:...

National Minority Quality Forum Announces Support for Government Noninterference in Drug Price Negotiations

2013-03-19 08:27:58

WASHINGTON, March 19, 2013 /PRNewswire-USNewswire/ -- The National Minority Quality Forum (The Forum) announces today its support for government noninterference in drug price negotiations for Medicare Part D. A provision of the Social Security Act prohibits the Secretary of Health and Human Services from interfering in the negotiations between drug manufacturers, pharmacies, and sponsors of prescription drug plans (PDPs) involved in Part D of Medicare, or from requiring a particular...

AAJ: Patient Safety at Risk with SCOTUS Mutual v. Bartlett

2013-03-18 16:24:31

WASHINGTON, March 18, 2013 /PRNewswire-USNewswire/ -- For the third time in a matter of minutes, Karen Bartlett puts drops in her eyes to substitute for the tears she no longer produces. Legally blind, Karen's eyes are a noticeable injury from her Stevens-Johnson syndrome (SJS), a lifetime condition resulting from taking sulindac, a generic drug prescribed for shoulder pain. Tomorrow, the U.S. Supreme Court will hear Karen's case about the legal responsibility generic drug...

Pew Commends Senators Gillibrand and Feinstein for Working to Shine Light on Antibiotics Practices

2013-03-18 12:28:53

Senate HELP Committee Neglects its Public Health Mission WASHINGTON, March 18, 2013 /PRNewswire-USNewswire/ -- The Senate Health, Education, Labor and Pensions Committee today released the Animal Drug User Fee Act for committee vote on Wednesday, which did not include provisions that would improve the Food and Drug Administration's annual reporting of antibiotic sales for use on industrial farms. The following statement should be attributed to Laura Rogers, project director, The Pew...

Watertree Health Rolls Out National Prescription Discount Card Program

2013-03-18 12:28:12

Helping make prescription medicines affordable to all people NEW YORK, March 18, 2013 /PRNewswire/ -- Watertree Health, a privately held company founded in 2010, is announcing the national launch of its free Prescription Discount Card program. The card has been introduced across the country over the last year, through the company's unique community-based initiative, using a network of local representatives. (Logo: http://photos.prnewswire.com/prnh/20130318/NY78695LOGO ) For more...

Perrigo to Begin Shipments of Guaifenesin Extended-Release 600mg Tablets, the First Store Brand Equivalents to Mucinex® 600mg Extended Release Tablets

2013-03-18 08:31:08

ALLEGAN, Mich., March 18, 2013 /PRNewswire/ -- Perrigo Company (Nasdaq: PRGO; TASE) today announced that it has begun shipments of Guaifenesin 600mg Extended-Release tablets in a launch to its retail and wholesale customers. This major new product is the first product that is generically equivalent to Mucinex® 600mg Extended Release tablets. The product will be packaged and marketed under store and proprietary brands and will be a high quality, value alternative to Mucinex®...

EAS Consulting Group, Experts in Quality Regulatory Services Related to FDA Issues, Announces Upcoming Dietary Supplement Seminars in Salt Lake City

2013-03-18 08:30:34

Dietary Supplement Good Manufacturing Practices to Be Held on June 11-12; Dietary Supplement Labeling Takes Place on June 13-14 ALEXANDRIA, Va., March 18, 2013 /PRNewswire/ -- EAS Consulting Group, a leader in providing quality regulatory consulting services in all FDA-related matters, is pleased to announce two trainings on dietary supplements in Salt Lake City. The Dietary Supplement Good Manufacturing Practices (GMPs) and Dietary Supplement Labeling regulations will take place...

Medbox Acquires 50% of MedVend and its Patented Technologies

2013-03-15 08:27:10

HOLLYWOOD, Calif., March 15, 2013 /PRNewswire/ -- Medbox, Inc. (OTC Markets: MDBX) (www.medboxinc.com), a leader in providing industry specific consulting services and patented systems to the medical and retail industries worldwide, announced acquiring a 50% partnership stake in MedVend, LLC (www.medvendonline.com), a Michigan based bio-tech company that developed a patented automated medicine dispensing machine used for traditional prescription pharmaceutical dispensing. The deal...

Surveyed U.S. Endocrinologists and PCPs Use E-Prescribing for 76 Percent of Their Medicare Patients and 79 Percent of Their Non-Medicare Patients

2013-03-14 12:23:54

Approximately 80 Percent of PCPs and Endocrinologists Say They Would Prescribe a Less Expensive DPP-IV Inhibitor to Their Patients with Type 2 Diabetes or Hypertension, According to a New Report from Decision Resources BURLINGTON, Mass., March 14, 2013 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, on average, surveyed U.S. endocrinologists and primary care physicians (PCPs) use...